載入...
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
High platelet counts in essential thrombocythemia (ET) can be effectively lowered by treatment with either anagrelide or hydroxyurea. In 259 previously untreated, high-risk patients with ET, diagnosed according to the World Health Organization classification system, the efficacy and tolerability of...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Hematology
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3591796/ https://ncbi.nlm.nih.gov/pubmed/23315161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-07-443770 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|